Skip to content

NewAmsterdam Pharma Co N.V.

NAMS· NasdaqCore metricsCIK 1936258

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -3.90%
Market cap
$2.39B
119.93M shares
Filings
417
$19.16M
Q3 2026−50.6% FY25 yoy
-$17.39M
Q3 2026N/M FY25 yoy
-$44.19M
Q3 2026N/M FY25 yoy
-$109.89M
Q3 2026derivedN/M FY25 yoy
-$0.14
Q3 2026N/M FY25 yoy
$423.13M
Q3 2026−36.5% FY25 yoy
$2.39B
—
92.2×
3.8×
-6.31%
—

Twelve months to Sep 30, 2026 · derived

Price

$19.9450.01%$19.95past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$22.50MFY 2025
$102.69M0FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$22,503,000reported
FY 20242024-12-31$45,563,000reported
FY 20232023-12-31$14,090,000reported
FY 20222022-12-31$102,694,000reported

Pharmaceutical preparations

NewAmsterdam Pharma Co N.V. is the 151st largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

NewAmsterdam Pharma Co N.V. · CIK 1936258 · Engraved from SEC EDGAR